| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (279kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-430575
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.43057
Zusammenfassung
Effectors from the immune system can modulate the course and possibly the early development of gliomas. We, therefore, hypothesized that autoimmune diseases associated with increased immune-surveillance may also modulate the risk of human glioma. To test this hypothesis, we used data from the well-validated Clinical Practice Research Datalink (CPRD) GOLD from the UK to analyze the association of ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags